Influenza

In a recent study, researchers examined whether high-dose influenza vaccine options could provide better protection in adults aged 50 to 64 years with conditions that increase the risk of influenza...

The US Food and Drug Administration has approved a generic oral suspension of a common influenza drug to prevent and treat the virus in adults and children.

Rapid and accurate influenza diagnostic tests can help improve patient care. In a recent study, researchers aimed to assess the efficacy of novel influenza diagnostic tests compared with traditional ones. ...

The CDC’s Advisory Committee on Immunization Practices has released is updated recommendations for the use of seasonal influenza vaccines during the 2017-2018 season.

In a recent study, researchers compared the effects of a high-dose trivalent influenza vaccine with a standard-dose vaccine in adults 65 years of age or older.

Microneedle patches are well-tolerated, have few adverse effects, and generated robust antibody responses.

A recent study examined the safety, immunogenicity, and acceptability of a dissolvable microneedle patch vaccination against influenza.

A study shows that live attenuated influenza vaccines increase immune responses in children, and could potentially lead to universal influenza vaccines.

The CDC released its 2016-2017 interim estimate for the effectiveness of the seasonal influenza vaccine.

The CDC has published its findings from January 1 through February 4 on the current status of influenza outbreaks across the country.